These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 15983210)

  • 1. Targeted inactivation of hepatocyte growth factor receptor c-met in beta-cells leads to defective insulin secretion and GLUT-2 downregulation without alteration of beta-cell mass.
    Roccisana J; Reddy V; Vasavada RC; Gonzalez-Pertusa JA; Magnuson MA; Garcia-Ocaña A
    Diabetes; 2005 Jul; 54(7):2090-102. PubMed ID: 15983210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-cell-specific ablation of the hepatocyte growth factor receptor results in reduced islet size, impaired insulin secretion, and glucose intolerance.
    Dai C; Huh CG; Thorgeirsson SS; Liu Y
    Am J Pathol; 2005 Aug; 167(2):429-36. PubMed ID: 16049329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2.
    Guillam MT; Hümmler E; Schaerer E; Yeh JI; Birnbaum MJ; Beermann F; Schmidt A; Dériaz N; Thorens B
    Nat Genet; 1997 Nov; 17(3):327-30. PubMed ID: 9354799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transgenic overexpression of hepatocyte growth factor in the beta-cell markedly improves islet function and islet transplant outcomes in mice.
    García-Ocaña A; Vasavada RC; Cebrian A; Reddy V; Takane KK; López-Talavera JC; Stewart AF
    Diabetes; 2001 Dec; 50(12):2752-62. PubMed ID: 11723058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of dominant-negative mutant hepatocyte nuclear fctor-1 alpha in pancreatic beta-cells causes abnormal islet architecture with decreased expression of E-cadherin, reduced beta-cell proliferation, and diabetes.
    Yamagata K; Nammo T; Moriwaki M; Ihara A; Iizuka K; Yang Q; Satoh T; Li M; Uenaka R; Okita K; Iwahashi H; Zhu Q; Cao Y; Imagawa A; Tochino Y; Hanafusa T; Miyagawa J; Matsuzawa Y
    Diabetes; 2002 Jan; 51(1):114-23. PubMed ID: 11756330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion.
    Wang MY; Koyama K; Shimabukuro M; Mangelsdorf D; Newgard CB; Unger RH
    Proc Natl Acad Sci U S A; 1998 Sep; 95(20):11921-6. PubMed ID: 9751766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of GLUT-2 antisense RNA in beta cells of transgenic mice leads to diabetes.
    Valera A; Solanes G; Fernández-Alvarez J; Pujol A; Ferrer J; Asins G; Gomis R; Bosch F
    J Biol Chem; 1994 Nov; 269(46):28543-6. PubMed ID: 7961797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose uptake, utilization, and signaling in GLUT2-null islets.
    Guillam MT; Dupraz P; Thorens B
    Diabetes; 2000 Sep; 49(9):1485-91. PubMed ID: 10969832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered beta-cell distribution of pdx-1 and GLUT-2 after a short-term challenge with a high-fat diet in C57BL/6J mice.
    Reimer MK; Ahrén B
    Diabetes; 2002 Feb; 51 Suppl 1():S138-43. PubMed ID: 11815473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High Km of GLUT-2 glucose transporter does not explain its role in insulin secretion.
    Lachaal M; Spangler RA; Jung CY
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E914-9. PubMed ID: 8279547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of HGF/c-Met signaling in pancreatic β-cells leads to incomplete maternal β-cell adaptation and gestational diabetes mellitus.
    Demirci C; Ernst S; Alvarez-Perez JC; Rosa T; Valle S; Shridhar V; Casinelli GP; Alonso LC; Vasavada RC; García-Ocana A
    Diabetes; 2012 May; 61(5):1143-52. PubMed ID: 22427375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic islets from cyclin-dependent kinase 4/R24C (Cdk4) knockin mice have significantly increased beta cell mass and are physiologically functional, indicating that Cdk4 is a potential target for pancreatic beta cell mass regeneration in Type 1 diabetes.
    Marzo N; Mora C; Fabregat ME; Martín J; Usac EF; Franco C; Barbacid M; Gomis R
    Diabetologia; 2004 Apr; 47(4):686-94. PubMed ID: 15298346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose transporter isotypes switch in T-antigen-transformed pancreatic beta cells growing in culture and in mice.
    Tal M; Thorens B; Surana M; Fleischer N; Lodish HF; Hanahan D; Efrat S
    Mol Cell Biol; 1992 Jan; 12(1):422-32. PubMed ID: 1729614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and function of GLUT-1 and GLUT-2 glucose transporter isoforms in cells of cultured rat pancreatic islets.
    Tal M; Liang Y; Najafi H; Lodish HF; Matschinsky FM
    J Biol Chem; 1992 Aug; 267(24):17241-7. PubMed ID: 1512261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic reexpression of GLUT1 or GLUT2 in pancreatic beta cells rescues GLUT2-null mice from early death and restores normal glucose-stimulated insulin secretion.
    Thorens B; Guillam MT; Beermann F; Burcelin R; Jaquet M
    J Biol Chem; 2000 Aug; 275(31):23751-8. PubMed ID: 10823833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of the glucose transporter content of islet cell lines: implications for glucose-stimulated insulin release.
    Brant AM; McCoid S; Thomas HM; Baldwin SA; Davies A; Parker JC; Gibbs EM; Gould GW
    Cell Signal; 1992 Nov; 4(6):641-50. PubMed ID: 1489658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of insulin secretory function in two mouse models with different susceptibility to beta-cell failure.
    Kooptiwut S; Zraika S; Thorburn AW; Dunlop ME; Darwiche R; Kay TW; Proietto J; Andrikopoulos S
    Endocrinology; 2002 Jun; 143(6):2085-92. PubMed ID: 12021173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of biotin supplementation in the diet on insulin secretion, islet gene expression, glucose homeostasis and beta-cell proportion.
    Lazo de la Vega-Monroy ML; Larrieta E; German MS; Baez-Saldana A; Fernandez-Mejia C
    J Nutr Biochem; 2013 Jan; 24(1):169-77. PubMed ID: 22841397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of hepatocyte growth factor/c-Met signaling enhances pancreatic beta-cell death and accelerates the onset of diabetes.
    Mellado-Gil J; Rosa TC; Demirci C; Gonzalez-Pertusa JA; Velazquez-Garcia S; Ernst S; Valle S; Vasavada RC; Stewart AF; Alonso LC; Garcia-Ocaña A
    Diabetes; 2011 Feb; 60(2):525-36. PubMed ID: 20980460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of normal and novel glucokinase mRNAs in anterior pituitary and islet cells.
    Hughes SD; Quaade C; Milburn JL; Cassidy L; Newgard CB
    J Biol Chem; 1991 Mar; 266(7):4521-30. PubMed ID: 1999433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.